SS seems very clumsy and difficult to navigate and I don't think I'll find Enumerator's posts without a lot of work.
Perhaps you can answer some questions I am working on.
I still find the whole patent space very tricky to work out. Is every research that uses shRNAi automatically subject to Benitec's patent; or only viral vector shRNAi, or only some viral vector shRNAi which specifically uses Benitecs methods under patent? Is any multi cassette promoter method using more than 3 promoter/RNAi/terminator components at once subject to Benitec's patent, whether ddRNAi or siRNAi based? If it is the most wide interpretation of their patent position, then there is new research published at least weekly on shRNAi. Is Benitec simply letting researchers get on with it, to widen the field, but only making patent fees payable once the research is monetised? Many reagent companies are making money out of shRNAi reagents. Do you think Benitec will start to get more fees from them now that the patent position is strong?
BLT Price at posting:
80.0¢ Sentiment: LT Buy Disclosure: Held
